Stock listing
A0LA5K Stock Price, News, Filings & Events — Swedish Orphan Biovitrum Ab
Selected listing: A0LA5K · LSX · EUR · DE
This page tracks Swedish Orphan Biovitrum Ab's A0LA5K:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0LA5K:LSX. A0LA5K:LSX is the stock-level entry point for investors researching Swedish Orphan Biovitrum Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Swedish Orphan Biovitrum Ab (SOBI) is a public company based in Sweden, specializing in the development and commercialization of innovative therapies for rare diseases. With a market capitalization of approximately 16.14 billion SEK, SOBI focuses on providing solutions that address unmet medical needs. The company is committed to improving the quality of life for patients through its specialized products and services.
- Ticker
- A0LA5K:LSX
- Asset type
- Stock
- Market cap
- $15.59B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Swedish Orphan Biovitrum Ab A0LA5K:LSX stock context
This page tracks Swedish Orphan Biovitrum Ab's A0LA5K:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0LA5K:LSX. A0LA5K:LSX is the stock-level entry point for investors researching Swedish Orphan Biovitrum Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Swedish Orphan Biovitrum Ab (SOBI) is a public company based in Sweden, specializing in the development and commercialization of innovative therapies for rare diseases. With a market capitalization of approximately 16.14 billion SEK, SOBI focuses on providing solutions that address unmet medical needs. The company is committed to improving the quality of life for patients through its specialized products and services.
Latest news from Swedish Orphan Biovitrum Ab
Swedish Orphan Biovitrum : Sobi and Innate announce partnership is now effective following completion of closing conditions
September 16, 2026
Sobi and Innate announce partnership is now effective following completion of closing conditions
September 15, 2026
Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome
September 9, 2026
Sobi has completed an issue of class C shares
August 31, 2026
Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
August 10, 2026
Swedish Orphan Biovitrum Ab earnings calls
Swedish Orphan Biovitrum AB (SOBI) Q2 2026 Earnings Call
July 16, 2026 · Replay with transcript and chapters
Swedish Orphan Biovitrum AB (SOBI) Q1 2026 Earnings Call
April 28, 2026 · Replay with transcript and chapters
Swedish Orphan Biovitrum AB (SOBI) Q4 2025 Earnings Call
February 5, 2026 · Replay with transcript and chapters
Swedish Orphan Biovitrum AB (SOBI) Q3 2025 Earnings Call
October 20, 2025 · Replay with transcript and chapters
Swedish Orphan Biovitrum AB (SOBI) Q2 2025 Earnings Call
July 16, 2025 · Replay with transcript and chapters
Swedish Orphan Biovitrum AB (SOBI) Q1 2025 Earnings Call
April 29, 2025 · Replay with transcript and chapters
Research Swedish Orphan Biovitrum Ab
Swedish Orphan Biovitrum Ab investor report
Review AI stock analysis and investor report context for A0LA5K:LSX.
Swedish Orphan Biovitrum Ab company profile
View the public company page for Swedish Orphan Biovitrum Ab on 6ix.
Swedish Orphan Biovitrum Ab news
Read company news and market updates connected to Swedish Orphan Biovitrum Ab.
Swedish Orphan Biovitrum Ab investor events
Find investor webinars, events, and replay context for Swedish Orphan Biovitrum Ab.
Alternate listings
SOBI:OMXSTO
SE · SEK
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
BIOVF:OTC
US · USD
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
SWOBY:OTC
US · USD
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
B6E:GETTEX
DE · EUR
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
1SOBI:MIL
IT · EUR
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
0MTD:LSIN
GB · SEK
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
SOBIS:AQUISEU
GB · SEK
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
SOBIN:BMV
MX · MXN
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
A0LA5K:LS
DE · EUR
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
SOBIN:BIVA
MX · MXN
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
B6E:FWB
DE · EUR
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.
SOBIS:AQUISUK
GB · SEK
Alternate listing for Swedish Orphan Biovitrum Ab; the primary context on this page is A0LA5K:LSX.